About the job
Company Overview:
Compass Pathways plc (Nasdaq: CMPS) is a pioneering biotechnology firm focused on enhancing patient access to innovative, evidence-based treatments for mental health. With headquarters in London and a significant presence in New York City, our mission is to develop groundbreaking therapies aimed at improving the lives of individuals suffering from mental health disorders, particularly those who have not found relief with existing treatments.
We are at the forefront of transforming mental health treatment paradigms, concentrating on rapid and lasting responses through our investigational COMP360 synthetic psilocybin therapy, which holds Breakthrough Therapy designation from the FDA and Innovative Licensing and Access Pathway (ILAP) status in the UK for treatment-resistant depression (TRD). Currently in phase 3 trials for TRD, we have completed phase 2 studies for post-traumatic stress disorder (PTSD) and anorexia nervosa and plan to initiate additional late-stage studies for PTSD. Our vision is a world where mental health encompasses not only the absence of illness but the ability to thrive.
Job Overview:
The Associate Director of Commercial Forecasting is crucial in steering Compass Pathways' commercial success through the development of precise sales forecasts, including demand volumes, ex-factory volumes, and inventory management across various time horizons.

